EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of CFTR Dysfunction and Responsiveness to CFTR Modulators in COPD Bronchial Air–Liquid Interface Cultures

Nikhil T Awatade, Kurtis F Budden iD, Prabuddha S Pathinayake iD, Andrew T Reid, Kristy S Nichol, Peter A B Wark

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27198803 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Nikhil T Awatade und 5 weiteren Autor:innen. Beteiligte Einrichtung: Immune Health Program, Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW 2308, Austral…. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Pulmonary Disease, Chronic Obstructive, Bronchi. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: John Hunter Hospital, School of Medicine and Public Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increasing evidence suggests that acquired dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel occurs as a result of cigarette smoke exposure in chronic obstructive pulmonary disease (COPD). CFTR-targeted therapies were developed to treat genetic CFTR defects in cystic fibrosis, but they have not demonstrated consistent clinical efficacy in small trials of patients with COPD. Here, we aimed to characterize CFTR and other ion channel activity and ciliation in primary bronchial epithelial cells (pBECs) from COPD donors compared with healthy controls, and to determine the extent to which CFTR dysfunction can be rescued by clinically relevant CFTR modulators. Air–liquid interface (ALI) cultures generated from conditionally reprogrammed (CR) primary bronchial epithelial cells (pBECs) obtained from healthy controls (n = 7) and COPD donors (n = 7) were assessed for transepithelial electrical resistance, immunofluorescence, cilia activity, ion channel function and expression of cell-type-associated markers at the transcript level. COPD cultures exhibited reduced ciliated area, accompanied by significantly decreased forskolin/IBMX-stimulated CFTR-mediated anion transport and ATP-induced calcium-activated chloride currents compared with healthy-control cultures, despite comparable CFTR mRNA expression. Treatment with CFTR potentiators (VX-770, GLPG1837 and icenticaftor) resulted in modest and highly variable functional responses, with no statistically significant improvement compared with vehicle-treated controls. CFTR function was not significantly associated with cumulative smoking exposure (pack-years) in this cohort, suggesting that smoking burden alone may not account for the observed inter-individual variability in acquired CFTR dysfunction. Collectively, these findings demonstrate abnormalities in ion transport and ciliation in the COPD airway epithelium consistent with an acquired CFTR dysfunction phenotype, but indicate that these abnormalities are not readily reversed by the tested CFTR potentiators. These results highlight differences between genetic and acquired CFTR dysfunction and underscore the need for alternative or combinatorial therapeutic strategies targeting epithelial dysfunction in COPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic Fibrosis Transmembrane Conductance RegulatorPulmonary Disease, Chronic ObstructiveBronchiHumansQuinolonesEpithelial CellsCells, CulturedCiliaAminophenolsMaleFemaleMiddle Aged

Stichwörter der Autor:innen

CFTRCOPDairway epitheliumair–liquid interfaceicenticaftorivacaftor

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorQuinolonesCFTR protein, humanivacaftorAminophenols

Autor:innen und Institutionen

  • Immune Health Program, Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW 2308, Australia.
  • School of Medicine and Public Health, University of Newcastle, Newcastle, NSW 2308, Australia.
  • Impact and Evaluation, Hunter Medical Research Institute, Locked Bag 1000, New Lambton Heights, Newcastle, NSW 2305, Australia.
  • School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, NSW 2308, Australia.
  • Infection Research Program, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW 2308, Australia.
  • Breathing and Lung Health Research Program, Hunter Medical Research Institute, New Lambton Heights, Newcastle, NSW 2305, Australia.

ORCID-Profile: Kurtis F Budden, Prabuddha S Pathinayake

Förderung

  • John Hunter Hospital
  • School of Medicine and Public Health

Zitieren

APA

Awatade, N. T., Budden, K. F., Pathinayake, P. S., Reid, A. T., Nichol, K. S., & Wark, P. A. B. (2026). Assessment of CFTR Dysfunction and Responsiveness to CFTR Modulators in COPD Bronchial Air–Liquid Interface Cultures. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198803

Vancouver

Awatade NT, Budden KF, Pathinayake PS, Reid AT, Nichol KS, Wark PAB. Assessment of CFTR Dysfunction and Responsiveness to CFTR Modulators in COPD Bronchial Air–Liquid Interface Cultures. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198803

BibTeX
@article{Awatade2026,
  author = {Awatade, Nikhil T and Budden, Kurtis F and Pathinayake, Prabuddha S and Reid, Andrew T and Nichol, Kristy S and Wark, Peter A B},
  title = {Assessment of CFTR Dysfunction and Responsiveness to CFTR Modulators in COPD Bronchial Air–Liquid Interface Cultures},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27198803}
}
Kostenlos starten →